Author

K.-J. Won

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:metabolomics· 2 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

H. Jeong· 2 shared H. Lee· 2 shared X. Yang· 2 shared C. M. Crnkovic· 1 shared E. B. Chang· 1 shared E. Chung· 1 shared G. Guzman· 1 shared J. Orjala· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

H. Jeong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Phenylpropionc acid produced by gut microbiota alleviates acetaminophen-induced hepatotoxicity

S. Cho, K.-J. Won, X. Yang, V. Leone, E. B. Chang, E. Chung, J.-S. Park, G. Guzman, H. Lee, H. Jeong

This study shows that phenylpropionic acid from gut microbiota reduces acetaminophen-induced liver damage in mice by inhibiting the toxic enzyme CYP2E1.

bioRxiv · Jun 10, 2020 · PreprintPharmacology & Toxicology

Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites

Y. Guo, C. M. Crnkovic, K.-J. Won, X. Yang, J. R. Lee, J. Orjala, H. Lee, H. Jeong

This study identifies gut bacteria, particularly Clostridiales, as a source of tacrolimus metabolism, producing less potent metabolites that may explain variable drug exposure after oral dosing.

bioRxiv · Oct 1, 2018Pharmacology & Toxicology